CCOI:NASDAQCogent Communications Holdings, Inc. Analysis
Data as of 2026-05-27 - not real-time
$21.62
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Cogent Communications is trading at $21.62, just below the calculated resistance of $24.23 and above the support level of $14.82, with the 20‑day SMA ($18.25) sitting under price while the 50‑day SMA ($19.80) remains below, indicating a narrow upside window. The RSI of 61.7 suggests modest momentum, yet the overall trend is classified as bearish and volume is on a decreasing trajectory, underscoring waning buying pressure. Technicals show a bullish MACD histogram (+0.51) despite a negative MACD line, hinting at a potential short‑term bounce that may be constrained by the broader downtrend. Volatility is extreme at 120% over the past 30 days and beta is elevated (≈1.7), amplifying price swings and risk of further drawdowns, as reflected in a historic max drawdown of over 70%.
Fundamentally, the company reports negative EPS (-$3.54 trailing, -$2.95 forward) and operating margins in the negative (-7.5%), with a profit margin of -19%, indicating earnings pressure. Cash flow is weak, with operating cash flow and free cash flow both negative, and debt levels exceed $2.6 B, raising solvency concerns despite a modest market cap of ~$1.1 B. The dividend yield appears attractive at 5.38% but the payout ratio is absurdly high (>560%), rendering the dividend unsustainable. Recent news adds uncertainty: a JP Morgan upgrade is offset by multiple securities‑fraud investigations, and Q1 sales missed expectations, contributing to mixed sentiment.
Fundamentally, the company reports negative EPS (-$3.54 trailing, -$2.95 forward) and operating margins in the negative (-7.5%), with a profit margin of -19%, indicating earnings pressure. Cash flow is weak, with operating cash flow and free cash flow both negative, and debt levels exceed $2.6 B, raising solvency concerns despite a modest market cap of ~$1.1 B. The dividend yield appears attractive at 5.38% but the payout ratio is absurdly high (>560%), rendering the dividend unsustainable. Recent news adds uncertainty: a JP Morgan upgrade is offset by multiple securities‑fraud investigations, and Q1 sales missed expectations, contributing to mixed sentiment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical trend with decreasing volume
- Legal investigations creating uncertainty
- Unsustainable dividend payout
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Cost‑reduction initiatives improving EBITDA
- Potential upside if price breaks above resistance
- JP Morgan upgrade adding analyst support
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistent negative earnings and cash flow
- High debt load relative to cash
- Ongoing regulatory and litigation risk
Key Metrics & Analysis
Financial Health
Revenue Growth-3.20%
Profit Margin-19.08%
P/E Ratio-7.3
ROE-877.28%
ROA-1.62%
P/B Ratio-9.9
Op. Cash Flow$-32096000
Free Cash Flow$-108703000
Industry P/E17.1
Technical Analysis
TrendBearish
RSI61.7
Support$14.82
Resistance$24.23
MA 20$18.25
MA 50$19.80
MA 200$26.78
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Target Price$21.27
Upside/Downside-1.61%
GradeOvervalued
TypeValue
Dividend Yield5.38%
Risk Assessment
Beta1.69
Volatility120.80%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.